Article
Errors in Germline Biomarker Testing: Significant Consequences and Missed Opportunities for Cancer Control in Patients and Their Families.
Cancer journal (Sudbury, Mass.) - 1 Jan 2026
Mahon Suzanne M, McLaughlin Laura A, Khemthong Usa, Owen Constance
Abstract excerpt
PURPOSE: Germline biomarker testing to assess inherited risk for developing malignancy has evolved quickly from testing for 1 or 2 genes from a few laboratories to ordering panels of 80 or more genes available from multiple laboratories. Many health professionals did not receive foundational information in training yet are expected to identify and manage care for individuals and families with germline risk....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
